These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29654251)

  • 1. Deciphering the mechanism of action of 089, a compound impairing the fungal cell cycle.
    Stefanini I; Rizzetto L; Rivero D; Carbonell S; Gut M; Heath S; Gut IG; Trabocchi A; Guarna A; Ben Ghazzi N; Bowyer P; Kapushesky M; Cavalieri D
    Sci Rep; 2018 Apr; 8(1):5964. PubMed ID: 29654251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids as targets for treatment of fungal infections.
    Rollin-Pinheiro R; Singh A; Barreto-Bergter E; Del Poeta M
    Future Med Chem; 2016 Aug; 8(12):1469-84. PubMed ID: 27502288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal Drugs: The Current Armamentarium and Development of New Agents.
    Robbins N; Wright GD; Cowen LE
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review.
    Martínez-Matías N; Rodríguez-Medina JR
    P R Health Sci J; 2018 Sep; 37(3):135-142. PubMed ID: 30188556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole: a new broad-spectrum antifungal agent.
    Kwon DS; Mylonakis E
    Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting virulence: a new paradigm for antifungals.
    Gauwerky K; Borelli C; Korting HC
    Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant Antifungal Lectins: Mechanism of Action and Targets on Human Pathogenic Fungi.
    Del Rio M; de la Canal L; Regente M
    Curr Protein Pept Sci; 2020; 21(3):284-294. PubMed ID: 31490746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential prescription of antifungals in invasive fungal infection: the importance of mechanism of action.
    Candel FJ; Matesanz M; Mensa J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S133-5. PubMed ID: 19013337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?
    Hull CM; Purdy NJ; Moody SC
    Future Microbiol; 2014; 9(3):307-25. PubMed ID: 24762306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling Fungal Resistance by Biofilm Inhibitors.
    Wu S; Wang Y; Liu N; Dong G; Sheng C
    J Med Chem; 2017 Mar; 60(6):2193-2211. PubMed ID: 28051303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.
    Hasim S; Coleman JJ
    Future Med Chem; 2019 Apr; 11(8):869-883. PubMed ID: 30994368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
    Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Schäfer-Korting M
    Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in human pathogenic fungi.
    Iwata K
    Eur J Epidemiol; 1992 May; 8(3):407-21. PubMed ID: 1397205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of fungal resistance: an overview.
    Balkis MM; Leidich SD; Mukherjee PK; Ghannoum MA
    Drugs; 2002; 62(7):1025-40. PubMed ID: 11985489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and prospects for targeting Hsp90 to treat fungal infections.
    Veri A; Cowen LE
    Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.